Key facts
- This page summarizes Matthew Stanton's Form 4 filing for Generation Bio Co. (GBIO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2025, 16:05.
Matthew Stanton - 10 Jan 2025 Form 4 Insider Report for Generation Bio Co. (GBIO)
- Reporting relationship
- CHIEF SCIENTIFIC OFFICER
- Issuer ticker
- GBIO
- Reported as of
- 10 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2025, 16:05:06 UTC
- Prior SEC filing
- 17 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shawna-Gay White, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Matthew Stanton filed Form 4 for Generation Bio Co. (GBIO) on 10 Jan 2025.
Change
- Previous filing in this sequence was filed on 17 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Matthew Stanton is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
SEC remarks
The reporting person will no longer serve as Generation Bio Co.'s chief scientific officer effective January 10, 2025. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of Generation Bio Co. and therefore will no longer report any such transactions on Form 4 or Form 5.